284 related articles for article (PubMed ID: 16424707)
41. Alterations of myocardial and vascular adrenergic receptor-mediated responses in Escherichia coli-induced septic shock in the rat.
Boillot A; Massol J; Maupoil V; Grelier R; Capellier G; Berthelot A; Barale F
Crit Care Med; 1996 Aug; 24(8):1373-80. PubMed ID: 8706494
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic effects of hypertonic saline on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats.
Shih CC; Chen SJ; Chen A; Wu JY; Liaw WJ; Wu CC
Crit Care Med; 2008 Jun; 36(6):1864-72. PubMed ID: 18496380
[TBL] [Abstract][Full Text] [Related]
43. Is prostacyclin responsible for producing the hyperdynamic response during early sepsis?
Wang P; Zhou M; Cioffi WG; Bland KI; Ba ZF; Chaudry IH
Crit Care Med; 2000 May; 28(5):1534-9. PubMed ID: 10834708
[TBL] [Abstract][Full Text] [Related]
44. Myocardial and vascular adrenergic alterations in a rat model of endotoxin shock: reversal by an anti-tumor necrosis factor-alpha monoclonal antibody.
Boillot A; Massol J; Maupoil V; Grelier R; Bernard B; Capellier G; Berthelot A; Barale F
Crit Care Med; 1997 Mar; 25(3):504-11. PubMed ID: 9118669
[TBL] [Abstract][Full Text] [Related]
45. Hemodynamic effects of early versus late glucocorticosteroid administration in experimental septic shock.
Mansart A; Bollaert PE; Seguin C; Levy B; Longrois D; Mallié JP
Shock; 2003 Jan; 19(1):38-44. PubMed ID: 12558142
[TBL] [Abstract][Full Text] [Related]
46. Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression.
Wu F; Wilson JX; Tyml K
Free Radic Biol Med; 2004 Oct; 37(8):1282-9. PubMed ID: 15451067
[TBL] [Abstract][Full Text] [Related]
47. Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide.
Pedoto A; Tassiopoulos AK; Oler A; McGraw DJ; Hoffmann SP; Camporesi EM; Hakim TS
Crit Care Med; 1998 Dec; 26(12):2021-8. PubMed ID: 9875915
[TBL] [Abstract][Full Text] [Related]
48. Low-level expression and limited role for the inducible isoform of nitric oxide synthase in the vascular hyporeactivity and mortality associated with cecal ligation and puncture in the rat.
Vromen A; Arkovitz MS; Zingarelli B; Salzman AL; Garcia VF; Szabó C
Shock; 1996 Oct; 6(4):248-53. PubMed ID: 8902940
[TBL] [Abstract][Full Text] [Related]
49. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock.
Avontuur JA; Tutein Nolthenius RP; Buijk SL; Kanhai KJ; Bruining HA
Chest; 1998 Jun; 113(6):1640-6. PubMed ID: 9631805
[TBL] [Abstract][Full Text] [Related]
50. Selective inhibition of inducible nitric oxide synthase: effects on hemodynamics and regional blood flow in healthy and septic sheep.
Booke M; Hinder F; McGuire R; Traber LD; Traber DL
Crit Care Med; 1999 Jan; 27(1):162-7. PubMed ID: 9934911
[TBL] [Abstract][Full Text] [Related]
51. Dexamethasone and recombinant human activated protein C improve myocardial function and efficiency during experimental septic shock.
Lemarie J; Blet A; Bouazza Y; Boisrame-Helms J; Meziani F; Levy B
Shock; 2014 Jun; 41(6):522-7. PubMed ID: 24837202
[TBL] [Abstract][Full Text] [Related]
52. Role of resveratrol in protecting vasodilatation function in septic shock rats and its mechanism.
Zhang ZS; Zhao HL; Yang GM; Zang JT; Zheng DY; Duan CY; Kuang L; Zhu Y; Wu Y; Li T; Liu LM
J Trauma Acute Care Surg; 2019 Dec; 87(6):1336-1345. PubMed ID: 31389921
[TBL] [Abstract][Full Text] [Related]
53. Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma.
Singh D; Richards D; Knowles RG; Schwartz S; Woodcock A; Langley S; O'Connor BJ
Am J Respir Crit Care Med; 2007 Nov; 176(10):988-93. PubMed ID: 17717202
[TBL] [Abstract][Full Text] [Related]
54. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
Grover R; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL
Crit Care Med; 1999 May; 27(5):913-22. PubMed ID: 10362413
[TBL] [Abstract][Full Text] [Related]
55. Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients.
Monnet X; Jabot J; Maizel J; Richard C; Teboul JL
Crit Care Med; 2011 Apr; 39(4):689-94. PubMed ID: 21263328
[TBL] [Abstract][Full Text] [Related]
56. The role of inducible nitric oxide synthase in the evolution of myocardial (dys)function during resuscitated septic shock: the missing loop.
Steendijk P
Crit Care Med; 2006 Feb; 34(2):545-7. PubMed ID: 16424742
[No Abstract] [Full Text] [Related]
57. [Value of pulse indicator continuous cardiac output monitoring of cardiac function in septic shock patients: a prospective study].
Yi M; Yao G; Guo X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jan; 27(1):22-7. PubMed ID: 25591432
[TBL] [Abstract][Full Text] [Related]
58. Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice.
Wu F; Wilson JX; Tyml K
Am J Physiol Regul Integr Comp Physiol; 2003 Jul; 285(1):R50-6. PubMed ID: 12637347
[TBL] [Abstract][Full Text] [Related]
59. Endothelial NOS (NOS3) impairs myocardial function in developing sepsis.
van de Sandt AM; Windler R; Gödecke A; Ohlig J; Zander S; Reinartz M; Graf J; van Faassen EE; Rassaf T; Schrader J; Kelm M; Merx MW
Basic Res Cardiol; 2013 Mar; 108(2):330. PubMed ID: 23397596
[TBL] [Abstract][Full Text] [Related]
60. Pralidoxime improves the hemodynamics and survival of rats with peritonitis-induced sepsis.
Mamadjonov N; Jung YH; Jeung KW; Lee HY; Lee BK; Youn CS; Jeong IS; Heo T; Min YI
PLoS One; 2021; 16(4):e0249794. PubMed ID: 33822820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
